Ozanimod Therapy in a Patient With Ulcerative Colitis and Multiple Sclerosis: Hitting 2 Birds With 1 Stone

Simultaneous occurrence of multiple sclerosis (MS) and ulcerative colitis (UC) is seldom encountered by clinicians and poses unique challenges. The sphingosine-1-phosphate receptor modulator ozanimod has been recently approved for UC. Ozanimod can be used in such scenarios where it can treat both co...

Descripción completa

Detalles Bibliográficos
Autores principales: Vuyyuru, Sudheer K., Morrow, Sarah A., Jairath, Vipul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857283/
https://www.ncbi.nlm.nih.gov/pubmed/36699181
http://dx.doi.org/10.14309/crj.0000000000000955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857283/
https://www.ncbi.nlm.nih.gov/pubmed/36699181
http://dx.doi.org/10.14309/crj.0000000000000955

Ejemplares similares